Monthly analysis: April 2021
There has been much optimism in the world since the beginning of 2021, while the corporate venturing arena has seen a rise in deals, exits and funding initiatives at least since the successful development and approval of coronavirus vaccines. This trend continued in April as well and is strengthening, as many countries see vaccine rollouts and a gradual easing of pandemic-related restrictions.
According to GCV Analytics, the number of corporate-backed deals from around the world was 336 in April, nearly 34% higher than the 251 rounds from the same month last year. Investment value stood at nearly $21.22bn in total estimated capital – nearly three times over the $7.31bn from April 2020, which was in the middle of a nearly global lockdown.
…
